Jennifer Pena
Head, Biology Field Application Scientists (BFAS) & IPS service, North America HUB Organoids (a Millipore Sigma Company)
Seminars
Monday 3rd November 2025
Target. Test. Treat: Leveraging Patient-derived Organoids for Smarter ADC Evaluation
2:00 pm
- Organoid technology is rapidly transforming preclinical drug development by providing patient-relevant models that capture the complexity of human disease
- Showcase real-world examples to demonstrate the translational power of organoids, bridging the gap between laboratory research and clinical applications
- Accelerating the journey from bench to bedside and supporting ADC development from lead selection to understanding mechanisms of action
